Lotus Bio-Technology Development Corp.

OTCPK:LBTD Stock Report

Market Cap: US$6.7m

Lotus Bio-Technology Development Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Hoyt Christopher

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Hoyt Christopher

1.3yrs

Tenure

Mr. Hoyt Christopher is Chief Executive Officer of Lotus Bio-Technology Development Corp. from July 2022. He has been in the health and wellness space for 12 years, acting as owner and operator of multimil...


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.